[Elsevier] LANCET - Bone mineral density as a surrogate endpoint for fracture risk reduction in clinical trials of osteoporosis therapies: an update on SABRE

Waltersport Post time 2024-4-26 03:22:26 | Show all posts |Read mode
Reward10points

DOI: 10.1016/S2213-8587(24)00092-5

Authors: Dennis M Black et al

LINK: https://www.thelancet.com/journals/landia/article/PIIS2213-8587(24)00092-5/abstract

Best Answer

Please adopt

View Full Content

Reply

Use magic Donate Report

All Reply1 Show all posts
vero08 Post time 2024-4-26 03:22:27 | Show all posts

This post has been completed

Completed attachments will be deleted within 24 hours.
Reply

Use magic Donate Report


Senior Member
  • post

  • reply

  • points

    4080

Latest Reply



Return to the list